Homepage
Sign up for the webinar on IMI's impact on dementia
IMI has a large portfolio of projects focusing on dementia covering the whole spectrum of medical research and drug development, including the role of specific genes in the disease, how to identify those at risk of the disease, and how to improve diagnosis, management, and the development of new treatments. A webinar on Tuesday 15 June will explore the impact of IMI's projects in this important field. This is the third in a series of events on IMI's impact - the first two focused on IMI's impact on diabetes and health data.
New institute to act as catalyst for wider use of real-world evidence in healthcare decision-making in Europe
New institute to act as catalyst for wider use of real-world evidence in healthcare decision-making in Europe moreThe real cost of RSV, a common but often fatal disease
The real cost of RSV, a common but often fatal disease more
IMI – radical collaboration in action
A new brochure, 'IMI - radical collaboration in action', showcases some recent IMI project successes, which include an approved vaccine for Ebola, insights into the genetics of Alzheimer’s disease, a new classification of diabetes, and advances on using liquid biopsies for cancer, as well as contributions to the fight against COVID-19.
IMI covid-19 response
Within weeks of the first reports of coronavirus in Europe, IMI launched a fast-track Call for proposals to develop therapeutics and diagnostics for current and future coronavirus outbreaks